Therapeutic effects of a small molecule agonist of the relaxin receptor ML290 in liver fibrosis-Reference-Cited by-同舟云学术

Therapeutic effects of a small molecule agonist of the relaxin receptor ML290 in liver fibrosis

Published:2019-08-16 Issue:11 Volume:33 Page:12435-12446
ISSN:0892-6638
Container-title:The FASEB Journal
language:en
Short-container-title:FASEB j.

Author:

Kaftanovskaya Elena M.¹,Ng Hooi Hooi¹,Soula Mariluz¹,Rivas Bryan¹,Myhr Courtney¹,Ho Brian A.¹,Cervantes Briana A.¹,Shupe Thomas D.²,Devarasetty Mahesh²,Hu Xin¹,Xu Xin¹,Patnaik Samarjit³,Wilson Kenneth J.³,Barnaeva Elena³,Ferrer Marc³,Southall Noel T.³,Marugan Juan J.³,Bishop Colin E.²,Agoulnik Irina U.¹,Agoulnik Alexander I.¹

Affiliation:

1. Department of Human and Molecular GeneticsHerbert Wertheim College of Medicine, Florida International UniversityMiamiFloridaUSA

2. Wake Forest Institute for Regenerative MedicineWake Forest School of MedicineWinston‐SalemNorth CarolinaUSA

3. NIH Chemical Genomics Center, National Center for Advancing Translational Sciences, National Institutes of HealthBethesdaMarylandUSA

Funder

National Institutes of Health

National Institute of Diabetes and Digestive and Kidney Diseases

National Institute of General Medical Sciences

Publisher

Wiley

Subject

Genetics,Molecular Biology,Biochemistry,Biotechnology